New trial for CMV retinitis.
D000906:Antibodies / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy / Q000628:therapy*; D017245:Foscarnet / Q000627:therapeutic use*; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D010919:Placebos
D000906:Antibodies; D000998:Antiviral Agents; D010919:Placebos; D017245:Foscarnet; D015774:Ganciclovir